As shown in Figure 2B and 2C, AZD5363 single agent treatment resulted in 60% tumor growth inhibition in SGC100 model (P < 0.0001) but had only marginal effects (23% tumor growth inhibition, p < 0.002) in the PTEN null SGC020 model. This evidence concerns the gene PTEN and neoplasm.